A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol

BACKGROUND: Concurrent chemoradiotherapy is a standard modality for locally advanced esophageal squamous cell carcinoma (ESCC) patients. Cisplatin combined with 5-fluorouracil continuous infusion (PF) remains the standard concurrent chemotherapy regimen. However, radiotherapy concurrent with PF show...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Radiat Oncol
Hlavní autoři: Chen, Yun, Zhu, Zhengfei, Zhao, Weixin, Li, Ling, Ye, Jinjun, Wu, Chaoyang, Tang, Huarong, Lin, Qin, Li, Jiancheng, Xia, Yi, Li, Yunhai, Zhou, Jialiang, Zhao, Kuaile
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2018
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5828310/
https://ncbi.nlm.nih.gov/pubmed/29482649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-018-0979-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky